Cargill's IngreVita EPA/DHA omega-3 oil takes a turn into non-GMO territory.
Cargill’s (Minneapolis) 2014-launched IngreVita EPA/DHA omega-3 oil has taken a turn into non-GMO territory. At the Natural Products Expo West trade show, the company unveiled a non-GMO version of the oil, which serves as a drop-in oil replacement in omega-3-enhanced functional foods such as breads, crackers, salad dressing, beverages, and dairy products.
The original IngreVita oil blends long-chain EPA and DHA omega-3 fatty acids with “proprietary” antioxidants and canola oil. This latest non-GMO version, IngreVita HO Sun, substitutes non-GMO high-oleic sunflower seed oil in place of the canola oil.
Both versions of the oil are shelf-stable, allowing products to be stored at ambient conditions. They are sensory neutral, imparting no fishy taste or smell on functional foods and beverages, the company says, adding that the oils are a cost-effective, drop-in replacement for a portion of existing oil in products.
Photo © iStockphoto.com/Tina_Rencelj
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.